Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134(4): 135-142
DOI: 10.1055/s-0028-1123971
DOI: 10.1055/s-0028-1123971
CME-Beitrag | Review article
Rheumatologie
© Georg Thieme Verlag KG Stuttgart · New York
Polymyalgia rheumatica
Polymyalgia rheumaticaFurther Information
Publication History
eingereicht: 22.9.2008
akzeptiert: 5.12.2008
Publication Date:
15 January 2009 (online)
Schlüsselwörter
Polymyalgia rheumatica - Diagnose - Differenzialdiagnose - Therapie
Keywords
polymyalgia rheumatica - diagnosis - differential diagnosis - therapy
Literatur
- 1 Ayoub W T, Franklin C M, Torretti D. Polymyalgia reumatica. Duration of therapy and long-term outcome. Am J Med. 1985; 79 309-315
- 2 Behn A R, Perera T, Myles A B. Polymyalgia rheumatica and corticosteroids: how much for how long?. Ann Rheum Dis. 1983; 42 374-378
- 3 Bird H A, Esselinckx W, Dixon A S, Mowat A G, Wood P H. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979; 38 434-439
- 4 Bird H A, Leeb B F, Montecucco C M. et al . A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis. 2005; 64 626-629
- 5 Blockmans D, de Ceuninck L, Vanderschueren S. et al . Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006; 55 131-137
- 6 Cantini F, Salvarani C, Niccoli L. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome: a prospective follow-up and magnetic resonance imaging study. Ann Rheum Dis. 1999; 58 230-236
- 7 Caporali R, Cimmino M, Ferracioloi G. et al . Prednisone plus methotrexate for polymyalgia rheumatica. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2004; 141 493-500
- 8 Chuang T Y, Hunder G G, Ilstrup D M, Kurland L T. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982; 97 672-680
- 9 Cimmino M A, Salvarani C, Macchioni P, Gerli R. et al . Systemic Vasculitis Study Group of the Italian Society for Rheumatology. Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids. Clin Exp Rheumatol. 2008; 26 395-400
- 10 Cutolo M, Montecucco C M, Cavagna L. et al . Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis. 2006; 65 1438-1443
- 11 Dasgupta B, Hutchings A, Matteson E L. Polymyalgia rheumatica: the mess we are now in and what we need to do about it. Arthritis Rheum. 2006; 55 518-520
- 12 Dasgupta B, Salvarani C, Schirmer M. et al . Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol. 2008; 35 270-277
- 13 Font R L, Prabhakaran C. Histologic parameters helpful to recognize steroid-treated temporal arteritis. An analysis of thirty-five cases. Br J Ophthalmol. 2007; 91 204-209
- 14 Gabriel S, Sunku J, Salvarani C. et al . Adverse outcomes and anti-inflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum. 1997; 40 1873-1878
- 15 Hellmich B, Gross W L. Polymyalgia rheumatica. Myalgisches Syndrom oder okkulte Vaskulitis?. Internist. 2005; 46 1233-1244
- 16 Hoffman G S, Cid M C, Rendt-Zagar K E. et al . Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis. Ann Intern Med. 2007; 146 621-630
- 17 Krüger K. Infliximab bei Riesenzellarteriitis und Polymyalgia rheumatica ineffektiv. Z Rheumatol. 2007; 66 536-537
- 18 Kyle V, Hazleman B L. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimes in the first 2 months. Ann Rheum Dis. 1989; 48 658-661
- 19 Lopez-Hoyos M, de Ruiz Alegria C, Blanco R. et al . Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Rheumatology. 2004; 4 655-657
- 20 Maradit-Kremers H M, Reinalda M S, Crowson C S. et al . Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol. 2005; 32 65-73
- 21 Narváez J, Nolla-Solé J M, Narváez J A, Clavaguera M T, Valverde-García J, Roig-Escofet D. Musculoskeletal manifestations in polymyalgia rheumatica and temporal arteritis. Ann Rheum Dis. 2001; 60 1060-1063
- 22 Narváez J, Narváez J A, Nolla J M. et al . Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology. 2005; 44 479-483
- 23 Olivieri I, Garcia-Porrua C, Padula A. et al . Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases. Rheumatol Int. 2007; 27 927-933
- 24 Salvarani C, Cantini F, Boiardi L, Hunder G G. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002; 347 261-271
- 25 Salvarani C, Macchioni P L, Manzini C. et al . Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica. Ann Intern Med. 2007; 146 631-639
- 26 Smeeth L, Cook C, Hall A J. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990 to 2001. Ann Rheum Dis. 2006; 65 1093-1098
- 27 Smetana G W, Shmerling R H. Does this patient have temporal arteritis?. JAMA. 2002; 287 92-101
- 28 Schmidt W A, Gromnica-Ihle E. Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler sonography of the temporal arteries. Rheumatology. 2002; 41 46-52
-
29 Schmidt W A, Gromnica-Ihle E, Caspary L, Stiegler H.
Polymyalgia rheumatica und Riesenzellarteriitis (Arteriitis temporalis). In: Dierkesmann R, Fleig WE, Heidrich H, Heimpel H, Koch KM, Meyer J, Müller OA, Specker C (Hrsg.) Rationelle Diagnostik und Therapie in der Inneren Medizin: Leitlinien. Elsevier. Urban & Fischer 2006 - 30 Weyand C M, Goronzy J J. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med. 2003; 139 505-515
Prof. Dr. med. Elisabeth Märker-Hermann
Klinik Innere Medizin IV (Rheumatologie,
klinische Immunologie und Nephrologie), HSK Dr. Horst Schmidt
Klinik GmbH
Ludwig Erhard Str. 100
D-65199 Wiesbaden
Phone: 0611/436-445
Fax: 0611/436-464
Email: Elisabeth.Maerker-Hermann@HSK-Wiesbaden.de